These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9705566

  • 1. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria.
    Zerwekh JE, Reed BY, Heller HJ, González GB, Haussler MR, Pak CY.
    Miner Electrolyte Metab; 1998; 24(5):307-13. PubMed ID: 9705566
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD, Zella JB, Prahl JM, DeLuca HF.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9733-7. PubMed ID: 12900504
    [Abstract] [Full Text] [Related]

  • 3. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
    Szabó A, Schmutz A, Pesian S, Schmidt-Gayk H, Ritz E, Reichel H.
    Nephrol Dial Transplant; 1998 Feb 19; 13(2):340-9. PubMed ID: 9509444
    [Abstract] [Full Text] [Related]

  • 4. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J, Kathpalia P, Bushinsky DA, Favus MJ.
    J Clin Invest; 1998 May 15; 101(10):2223-32. PubMed ID: 9593778
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts.
    Gross C, Musiol IM, Eccleshall TR, Malloy PJ, Feldman D.
    Biochem Biophys Res Commun; 1998 Jan 26; 242(3):467-73. PubMed ID: 9464239
    [Abstract] [Full Text] [Related]

  • 6. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC, Quach HP, Vieth R, Pang KS.
    Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451
    [Abstract] [Full Text] [Related]

  • 7. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G.
    Endocrinology; 2005 Feb 01; 146(2):825-34. PubMed ID: 15498883
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
    Roy S, Martel J, Tenenhouse HS.
    J Bone Miner Res; 1995 Dec 01; 10(12):1951-9. PubMed ID: 8619376
    [Abstract] [Full Text] [Related]

  • 9. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 01; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 10. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
    Staal A, van den Bemd GJ, Birkenhäger JC, Pols HA, van Leeuwen JP.
    Bone; 1997 Mar 01; 20(3):237-43. PubMed ID: 9071474
    [Abstract] [Full Text] [Related]

  • 11. Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.
    Smith SJ, Hayes ME, Selby PL, Mawer EB.
    Ann Rheum Dis; 1999 Jun 01; 58(6):372-8. PubMed ID: 10340962
    [Abstract] [Full Text] [Related]

  • 12. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.
    Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ.
    J Clin Invest; 1993 Feb 01; 91(2):661-7. PubMed ID: 8381825
    [Abstract] [Full Text] [Related]

  • 13. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
    Szabó A, Ritz E, Schmidt-Gayk H, Reichel H.
    Nephron; 1996 Feb 01; 73(4):619-28. PubMed ID: 8856261
    [Abstract] [Full Text] [Related]

  • 14. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.
    Nguyen TM, Lieberherr M, Fritsch J, Guillozo H, Alvarez ML, Fitouri Z, Jehan F, Garabédian M.
    J Biol Chem; 2004 Feb 27; 279(9):7591-7. PubMed ID: 14665637
    [Abstract] [Full Text] [Related]

  • 15. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
    Nishimura A, Shinki T, Jin CH, Ohyama Y, Noshiro M, Okuda K, Suda T.
    Endocrinology; 1994 Apr 27; 134(4):1794-9. PubMed ID: 8137744
    [Abstract] [Full Text] [Related]

  • 16. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D.
    Nguyen TM, Adiceam P, Kottler ML, Guillozo H, Rizk-Rabin M, Brouillard F, Lagier P, Palix C, Garnier JM, Garabedian M.
    J Bone Miner Res; 2002 Sep 27; 17(9):1728-37. PubMed ID: 12211444
    [Abstract] [Full Text] [Related]

  • 17. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
    Zhu W, Malloy PJ, Delvin E, Chabot G, Feldman D.
    J Bone Miner Res; 1998 Feb 27; 13(2):259-64. PubMed ID: 9495519
    [Abstract] [Full Text] [Related]

  • 18. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 27; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
    Gamblin GT, Liberman UA, Eil C, Downs RW, DeGrange DA, Marx SJ.
    J Clin Invest; 1985 Mar 27; 75(3):954-60. PubMed ID: 3872316
    [Abstract] [Full Text] [Related]

  • 20. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S, Li XY, Duell EA, Voorhees JJ.
    J Invest Dermatol; 1997 Apr 27; 108(4):513-8. PubMed ID: 9077483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.